Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PC-PLD1B Inhibitors

PC-PLD1B inhibitors are a class of chemical compounds that specifically target phosphatidylcholine-specific phospholipase D1B (PC-PLD1B), an enzyme involved in the metabolism of phospholipids within cellular membranes. PC-PLD1B catalyzes the hydrolysis of phosphatidylcholine to produce phosphatidic acid and choline, a reaction that plays a pivotal role in intracellular signaling and membrane dynamics. By modulating the activity of PC-PLD1B, these inhibitors help researchers explore the enzyme's role in various cellular processes such as vesicle trafficking, cytoskeletal rearrangement, and signal transduction pathways.

The design and synthesis of PC-PLD1B inhibitors involve advanced techniques like structure-based drug design and molecular docking studies to identify molecules that can effectively bind to the enzyme's active site. These inhibitors may include small organic compounds, peptides, or other biologically active molecules engineered to interact specifically with PC-PLD1B. High-throughput screening methods are often employed to evaluate the efficacy and specificity of potential inhibitors. By utilizing these compounds in laboratory settings, scientists can gain deeper insights into the functional mechanisms of PC-PLD1B and its impact on cellular physiology, contributing to a better understanding of lipid-mediated signaling pathways and membrane-associated processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Fluorouracil, as a nucleotide analog, could disrupt the synthesis of mRNA for PC-PLD1B, leading to a reduction in the production of the enzyme from the transcriptional stage.

D609

83373-60-8sc-201403
sc-201403A
5 mg
25 mg
$185.00
$564.00
7
(1)

D609's inhibition of phosphatidylcholine-specific phospholipase C may lead to a reduced production of diacylglycerol, which could decrease the stimulus for PC-PLD1B expression.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

Quercetin could downregulate the expression of PC-PLD1B by inhibiting upstream kinase signals, which may lead to reduced activation of transcription factors responsible for the enzyme's expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin may decrease the transcriptional activity of genes encoding PC-PLD1B by inhibiting nuclear factor-kappa B (NF-κB), a transcription factor that can enhance gene expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol could inhibit the expression of PC-PLD1B by activating sirtuins, which may lead to the deacetylation of histones and a more condensed chromatin structure, reducing transcriptional activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126, by inhibiting mitogen-activated protein kinase (MAPK), could lead to reduced phosphorylation of transcription factors that are crucial for PC-PLD1B expression, thus decreasing its expression levels.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein could downregulate PC-PLD1B expression by inhibiting tyrosine kinases that are part of the signaling cascade responsible for the enzyme's expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 may reduce PC-PLD1B expression by inhibiting phosphoinositide 3-kinases (PI3K), which are involved in the signaling pathways that control the transcription of the PC-PLD1B gene.